End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,528 KRW | -0.26% |
|
-1.74% | -29.75% |
Business Summary
Number of employees: 240
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals and Quasi-drugs
100.0
%
| 51,832 | 100.0 % | 51,955 | 100.0 % | +0.24% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
100.0
%
| 51,832 | 100.0 % | 51,955 | 100.0 % | +0.24% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ki-Ho Kim
CEO | Chief Executive Officer | 57 | - |
Sang-Jae Kim
CEO | Chief Executive Officer | 57 | - |
Chang-Bum Woo
AUD | Comptroller/Controller/Auditor | 55 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Woo-Jin Kim
BRD | Director/Board Member | 70 | - |
Sang-Jae Kim
CEO | Chief Executive Officer | 57 | - |
Gi-Woong Kim
BRD | Director/Board Member | 57 | 25/20/25 |
Ki-Ho Kim
CEO | Chief Executive Officer | 57 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 94,162,079 | 84,248,734 ( 89.47 %) | 41,783 ( 0.0444 %) | 89.47 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
GEMVAX&KAEL CO.,LTD. 5.52% | 2,209,169 | 5.52% | 17,487,627 $ |
SAMSUNG PHARM. CO., LTD. 0.05% | 46,310 | 0.05% | 54,353 $ |
Company contact information
SAMSUNG PHARMACEUTICAL Co., Ltd.
35 Jeyakgongdan 2-gil Hyangnam-eup
18622, Hwaseong
+
http://www.sspharm.co.kr![address SAMSUNG PHARM. Co., LTD.(A001360)](https://cdn.zonebourse.com/static/address/20699511.png)
Sector
1st Jan change | Capi. | |
---|---|---|
-29.75% | 104M | |
+20.76% | 43.77B | |
+28.00% | 22.83B | |
+20.25% | 15.56B | |
+18.82% | 14.34B | |
+55.83% | 12.96B | |
-0.05% | 6.79B | |
-12.70% | 6.41B | |
-8.87% | 5.73B | |
+14.65% | 5.69B |
- Stock Market
- Equities
- A001360 Stock
- Company SAMSUNG PHARM. Co., LTD.